Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/28/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Jag H. Khalsa

Wrong Dr. Jag H. Khalsa?

Chief, Medical Consequences Branc...

National Institutes of Health
31 Center Dr. MSC 2062 Building 31, Room B1-W30
Bethesda , Maryland 20892
United States

Company Description: The National Institutes of Health (NIH) - The Nation's Medical Research Agency - is comprised of 27 Institutes and Centers and is a component of the U. S....   more

Employment History

  • Member, Center On AIDS
  • Chief of the Medical Consequences Branch
  • Chief
    National Institute
  • Chief of the Medical Consequences Branch
    National Institute
  • Chief, Medical Consequences Branch, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
    National Institute on Drug Abuse, NIH
  • Chief
    Medical Consequences
  • Co-chair
    Center on AIDS
  • Pharmacologist and Health Scientist Administrator
    Center on AIDS
  • Chief, Medical Consequences Branch
    Division of Pharmacotherapies


  • Ph.D.
    National Institute
  • Ph.D. of NIDA
26 Total References
Web References
Other authors of the statement include: ..., 17 Dec 2013 [cached]
Other authors of the statement include: Ruth Wood of the University of Southern California; Alan Rogol of the University of Virginia; Fred Nyberg of Karolinska Institute in Stockholm, Sweden; Jag Khalsa of the National Institute of Drug Abuse in Bethesda, MD; and Larry Bowers of the United States Anti-Doping Agency in Colorado Springs, CO.
6 Ways to Boost Your Mental Acuity At Work | Ririan Project [cached]
"We know a lot about the acute effects of marijuana use, but researchers are just now beginning to look at the long-term effects," says Dr. Jag Khalsa of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse.
Dr. Jag H. Khalsa National ..., 3 April 2012 [cached]
Dr. Jag H. Khalsa National Institute of Health, USA
Dr. Jag Khalsa, with 47+ years of experience in drug research, serves as the Chief of the Medical Consequences Branch, NIDA/NIH/DHHS, is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), and the President of the American Society of Addiction Medicine (ASAM). He has a Ph.D. in neuro-psycho-pharmacology, post-doctoral trainings in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. BIOGRAPHY
- Jag H. Khalsa, MD, Chief, ..., 20 Nov 2012 [cached]
- Jag H. Khalsa, MD, Chief, National Institute on Drug Abuse
Jag Khalsa, PhD, ..., 13 July 2013 [cached]
Jag Khalsa, PhD, MS
"There are new formulations of buprenorphine, especially ones that can be implanted under the skin for a slow release of the medication so the patient does not have to get treatment more frequently," said the symposium organizer, Jag Khalsa, PhD, MS, Chief of the Medical Consequences Branch, National Institute on Drug Abuse (NIDA).
"We will discuss the liver complications of buprenorphine because it is important that we know not only the positive effects of the medication but also the potential adverse effects of the medication," Dr. Khalsa said.
Geetha Subramanian, MD, of NIDA, and Gavin Bart, MD, of the University of Minnesota, organized the session with Dr. Khalsa, and they both will be speakers.
Other People with the name "Khalsa":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.